Cytek Says Its San Diego Reagent Manufacturing Facility Secured EN ISO 13485:2016 Quality Management System Certification
Portfolio Pulse from Benzinga Newsdesk
Cytek's San Diego reagent manufacturing facility has achieved the EN ISO 13485:2016 Quality Management System Certification, indicating compliance with international standards for medical device quality management systems.
August 21, 2024 | 9:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cytek's San Diego facility has received the EN ISO 13485:2016 certification, which is a significant milestone in ensuring high-quality standards for its medical device manufacturing processes.
The certification is a positive development for Cytek as it demonstrates compliance with international quality standards, potentially enhancing its reputation and competitiveness in the medical device market. This could lead to increased investor confidence and a positive impact on the stock price.
CONFIDENCE 95
IMPORTANCE 80
RELEVANCE 90